ストックスクリーナーアプリを入手
75.08
0.35%
-0.26
プレマーケット:
74.98
-0.10
-0.13%
Kiniksa Pharmaceuticals International Plc (KNSA) 最新ニュース
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock Has Consensus Price Target of $87.38 According to Brokerages - MarketBeat
Kiniksa Pharmaceuticals, Ltd. (KNSA) stock price, news, quote and history - Yahoo Finance UK
Kiniksa Pharmaceuticals International, plc (KNSA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Kiniksa Pharmaceuticals International (KNSA) On The ARCALYST Story And Whether Shares Look Fully Valued - finance.yahoo.com
Kiniksa Pharmaceuticals (KNSA) Stock Slips 2.63% to $77.24 as Key Support Comes Into FocusEMA Signal - dars.gov.et
Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why - The Globe and Mail
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 3. - GuruFocus
Squarepoint Ops LLC Has $8.96 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
KNSA: Record Q2 revenue and pipeline progress highlight strong growth and future potential - TradingView
Megna Michael R Reduces Kiniksa Holdings to 29,062 Shares Following Sale and Other Transactions - Kalkine Media
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Fall 3.2% -- What GF Score of 46 Tells Investors - GuruFocus
Kiniksa Pharmaceuticals COO Moat Ross Executes Significant Equity Transactions on September 1, 2026 - Kalkine Media
Kiniksa sets a live healthcare talk for Sept. 9 - Stock Titan
Kiniksa CFO Mark Ragosa Reports RSU Vestings, Tax Withholding Share Sale, and New Equity Grants - Kalkine Media
Kiniksa Pharmaceuticals CEO Sanj K Patel Reports RSU Vesting, Share Sale, and New Equity Grants - Kalkine Media
Kiniksa (NASDAQ: KNSA) grants 14,600 options and 3,650 RSUs to Michael Megna - Stock Titan
Kiniksa (NASDAQ: KNSA) grants CMO options and RSUs - Stock Titan
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Michael Megna Sells 4,600 Shares - MarketBeat
Kiniksa Pharmaceuticals (KNSA) gives CEO new 10-year stock option grant - Stock Titan
Kiniksa (KNSA) CEO gets new equity grants vesting over four years - Stock Titan
Kiniksa Pharmaceuticals (KNSA) awards CFO new equity - Stock Titan
Officer at Kiniksa (NASDAQ: KNSA) plans $369K stock sale - stocktitan.net
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Braidwell LP - MarketBeat
Headlands Technologies LLC Purchases Shares of 18,161 Kiniksa Pharmaceuticals International, plc $KNSA - marketbeat.com
Kiniksa stock holds firm after a $243.6 million quarter - AD HOC NEWS
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kiniksa (KNSA) Earnings Reading: The EPS Result Is Below Expectation in the Current Update; Share Move: The Market Price Advances 1.03% at the CloseProfitability Analysis - vinanet.vn
Kiniksa Director Barry D Quart Donates 2,600 Class A Shares to Donor Advised Fund - Kalkine Media
Kiniksa (NASDAQ: KNSA) director gifts 2,600 shares to donor fund - Stock Titan
Kiniksa (KNSA) Earnings Report: EPS Comes in Below Forecast in the Reported Period; Trading Move: Shares Move 2.88% Lower on the DayEarnings Revision Downgrade - vinanet.vn
Handelsbanken Fonder AB Makes New $1.34 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Compelling Affordable Growth Story - ChartMill
Bank of America Corp DE Boosts Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3 - sharewise.com
Kiniksa Pharmaceuticals International, plc Class A Revenue Breakdown – BIVA:KNSA/N - TradingView
KNSA: ARCALYST drives record growth as pipeline advances and patient access, awareness, and satisfaction rise - TradingView
Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A Promising Outlook with 28% Potential Upside - DirectorsTalk Interviews
Kiniksa Pharmaceuticals (KNSA) Holds Near $76.53 as Bulls Eye $80.36 ResistanceHigh Reward Trades - careplusvn.com
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (NASDAQ:KNSA) - TradingView
Does Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)? - simplywall.st
Kiniksa Pharmaceuticals International, plc $KNSA Stake Raised by The Manufacturers Life Insurance Company - MarketBeat
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference - manilatimes.net
Kiniksa Pharmaceuticals to present at Canaccord Genuity Growth Conference on August 12, 2026 - Pluang
Kiniksa’s Aug. 12 fireside chat will stream live online - Stock Titan
Kiniksa Pharmaceuticals International PLC (KNSA) Stock News Today - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Lazard Asset Management LLC - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
31,391 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Bought by Financial Enhancement Group LLC - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by Janus Henderson Group PLC - MarketBeat
Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Strong Earnings Are Of Good Quality - 富途牛牛
Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Unlocking A 33.5% Upside Potential - DirectorsTalk Interviews
Dimensional Fund Advisors LP Purchases 128,417 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook - Yahoo Finance
0.18%
0.69%
大文字化:
|
ボリューム (24 時間):